Navigation Links
CVS Caremark Reports Record First Quarter Results
Date:5/2/2012

the board. Results in both our retail and PBM segments came in at the high end of our guidance, while EPS exceeded expectations. We also generated $2.4 billion in free cash during the quarter, which places us comfortably on track to achieve our goal for the year."

Mr. Merlo continued, "Our retail team has done an outstanding job capitalizing on the unprecedented opportunity for share gains afforded to us by the impasse between two of our industry peers. At the same time, while it is still early in the 2013 PBM selling season, we're optimistic about the opportunities and continue to feel very good about our position in the marketplace. With our stable business and unmatched breadth of capabilities, we are very well positioned for success in the 2013 and 2014 selling seasons."

Real Estate ProgramDuring the three months ended March 31, 2012, the Company opened 32 new retail drugstores and closed seven retail drugstores and one onsite pharmacy. In addition, the Company relocated 40 retail drugstores. As of March 31, 2012, the Company operated 7,428 locations, including 7,352 retail drugstores, 29 onsite pharmacies, 31 retail specialty pharmacy stores, 12 specialty mail order pharmacies and four mail order pharmacies in 44 states, the District of Columbia and Puerto Rico.

GuidanceThe Company raised its earnings guidance for the full year 2012 to reflect the solid first quarter performance and the anticipated benefit to second quarter results of approximately $0.03 to $0.04 per share from the continuing impasse between Walgreens and Express Scripts. The guidance adjustment reflects the potential estimated benefit if the stalemate continues only through the end of the second quarter and does not contemplate any potential benefit beyond the second quarter. Based on these assumptions, the Company currently expects to deliver Adjusted EPS of $3.23 to $3.33 and GAAP diluted earnings per share from continuing operations of $3.01 to $3.11 per s
'/>"/>

SOURCE CVS Caremark Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
2. CVS Caremark Ranks Among Top 25 Most Reputable Companies in America on Forbes List
3. CVS Caremark Corporation Announces Quarterly Dividend
4. CVS Caremarks Chief Medical Officer Troyen Brennan is Named to the National Commission on Physician Payment Reform
5. CVS Caremarks MinuteClinic to Deploy Allscripts EHR Nationally
6. CVS Caremark to Present at the RBC Healthcare Conference
7. Report: CVS Caremark Contributes Billions to Rhode Island Economy
8. NCPA Comments on FTC Action Against CVS Caremark, Vows to Continue PBM Transparency Efforts
9. FTC Ends Investigation of CVS Caremark
10. CVS Caremark Corporation Settles FTC Deceptive Pricing Charges
11. CVS Caremark Study Finds Integrated Pharmacy-Based Program Improved Diabetes Medication Initiation and Adherence Rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013  Omeros Corporation (NASDAQ: ... Drug Application (IND) to evaluate OMS824 in Huntington,s ... and Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase ... the brain linked to a wide range of ... schizophrenia. OMS824 has shown promising results in animal ...
(Date:5/23/2013)... 2013 SynCardia Systems, Inc. ( www.syncardia.com ), ... Canada and CE ( Europe ) approved ... Centre in Scotland , which boasts ... SynCardia temporary Total Artificial Heart powered by the ... Bodyworks Exhibition, one of the most advanced exhibitions of ...
(Date:5/23/2013)... May 23, 2013  PAREXEL International Corporation (NASDAQ: ... presenting at the Jefferies Healthcare Conference in New York.  ... and Chief Financial Officer, will be making a presentation ... on Monday, June 3, 2013. A live ... "Investors" section of PAREXEL,s website at www.PAREXEL.com ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3PAREXEL International To Present At Jefferies Healthcare Conference 2
... The U.S. Food and Drug Administration today approved ... to blood transfusions in patients with thalassemia, a genetic ... response to prior chelation therapy. (Logo: ... have excess iron in the body from the frequent ...
... Reata Pharmaceuticals, Inc. announced Friday a significant expansion ... program, bardoxolone methyl, and to continue advancing its earlier-stage ... executives: Paul Audhya, MD, as Vice ... Hilary Malone, Ph.D., as Vice President and Chief Regulatory ...
Cached Medicine Technology:FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body 2FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body 3Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 2Reata Pharmaceuticals Adds Executives to Management Team and Board of Directors 3
(Date:5/23/2013)... 2013 Cheap Concert Tickets announces that ... 2013 at stadiums throughout North America. This well known ... McCartney concert tickets to help McCartney fans see Sir Paul ... Tickets, states that she is also offering the customer appreciation ... Being a baby boomer, she is also a huge McCartney ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- The sensation of ... be traced back to a small molecule released in ... mice. Researchers say this molecule, known as ... through the central nervous system. Ultimately, this signal is ... humans and mice are similar, the researchers concluded that ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... badly as methamphetamine or crack cocaine, a new study ... mouth, or ,coke mouth, it is startling to see ... the same," said Dr. Mohamed Bassiouny, a professor of ... in Philadelphia. Methamphetamine, crack cocaine and soda -- ...
(Date:5/23/2013)... Chinese and U.S. scientists have used virus isolated from ... to determine whether the virus could infect and be ... mammalian model in influenza research, and efficient transmission of ... how well the same process might occur in people. ... Institute of Allergy and Infectious Diseases, part of the ...
(Date:5/23/2013)... 23, 2013 Special Learning, Inc., ... educational resources for the autism, Down syndrome and ... opening its first global autism treatment center and ... August. This new world-class program is the first ... evidence-based practices to treat and deliver exceptional education ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Ferrets, pigs susceptible to H7N9 avian influenza virus 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 3
... SOUTH EASTON, Mass., March 10 Pressure,BioSciences, Inc. ... has moved its,corporate offices to 14 Norfolk Avenue ... accommodate the Company,s transition from an,early-stage, research and ... Schumacher, PBI,s Founder, President, and CEO,commented: "We now ...
... CT System Brings More Innovative Diagnostics to the ... ... March 10 Encouraged by the outstanding,marketing success of the worldwide ... ) announces the 510(k) market clearance of four,new applications aimed at ...
... bone damage and stunted growth , , MONDAY, March 10 ... may place pediatric patients at risk for bone damage ... new red flag concerns a signal transduction inhibitor (STI) ... medulloblastoma brain tumors by short-circuiting tumor growth on the ...
... University of Michigan Health System have found a key ... discovery that lends new insight into fibromyalgia, an often-baffling ... found, pain decreased when levels of the brain molecule ... which appears in the journal Arthritis and Rheumatism, could ...
... Donation Helps Provide Free Surgical Treatments for Children ... Operation Smile, a,worldwide children,s medical charity, today announced ... part of a ,sharing smiles, campaign,from Windows Live. ... physical,examinations and surgical treatment to children in 26 ...
... A study by the Woolcock Institute of Medical Research in ... very mild or well-controlled asthma, regular treatment with low dose ... , The study published in this months edition of Primary ... and compared the effects of inhaled corticosteroids (ICS) and placebo ...
Cached Medicine News:Health News:Pressure BioSciences, Inc. Announces Move to New Corporate Offices 2Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 2Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 3Health News:Siemens Introduces New Dual Energy Applications to SOMATOM Definition 4Health News:New Drug for Brain Cancer Too Dangerous for Pediatric Patients 2Health News:New Drug for Brain Cancer Too Dangerous for Pediatric Patients 3Health News:Pain in fibromyalgia is linked to changes in brain molecule 2Health News:Windows Live $500,000 Donation Commemorates Operation Smile's 25th Anniversary 2Health News:Treatment for mild asthma leads to improved lung function 2
... The Hub Cap Limited ... to provide outstanding fixation and ... targeted solution for four corner ... the plate offers the kind ...
... cornerstones of the Acutrak family are the ... Together they are used primarily for secure ... upper extremity, but have been used for ... stabilized with these two systems have ranged ...
... decade KMI® revolutionized the wrist arthroplasty market ... Wrist System. We're at it again, with ... the Universal2. Like the original, the Universal2 ... live with debilitating arthritis. To date, we ...
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture....
Medicine Products: